Resources

All Resources

Our resource hub to discover reports, policy papers and other forms of informative content

Filter by

Innovative Agreements Framework

Many products coming to market are poorly served by traditional negotiation approaches. This document describes innovative agreements being used in jurisdictions outside Canada. We prepared it to guide discussions with the pCPA Governing Council on the merits of jointly developing an innovative agreements framework.

Learn more|View

Canadian Drug Access Pathway

The process for Canadians to access new medicines is extremely complex and involves several different federal, provincial, and territorial agencies. It takes two years following approval (732 days) for Canadian patients to get access to a drug in the public plan, whereas those in the private plan get access to a drug in less than one year (226 days).

Learn more|View

Bluesky Project

Reimagining Canada’s Approval and Reimbursement System for Innovative Medicines February 2022

Learn more|View

2022 Federal Pre-Budget Consultation

Our industry calls on the federal government to implement measures under the Biomanufacturing and Life Sciences Strategy to build a more vibrant life sciences sector and enhance patients’ access to innovative medicines.

Learn more|View

resources

Discover. Learn.
Understand.

Informative content to keep you up to date on the most pressing issues facing our industry.